IPHA Competitors & Alternatives
Compare Innate Pharma with similar stocks in the same industry
Biotechnology
IPHA
Main Stock$1.81
Tradestie Score
54
Market Cap
$182.31M
Revenue Growth
-0.5%
Analyst Upside
+231.5%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.94
|
$269.08M | - | 54 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.53
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.84
|
$202.58M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.08
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.10
|
$158.43M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.18
|
$133.50M | - | 64 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$22.93
|
$110.20M | - | 60 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$1.62
|
$72.18M | - | 49 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.89
|
$71.69M | - | 58 | Compare |
More IPHA Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry